Article
Progress toward cell‐directed therapy for phenylketonuria
9 Jul 2008
Abstract excerpt
Phenylketonuria (PKU) is one of the most common inborn errors of metabolism with an annual incidence of approximately 1:16,000 live births in North America. Contemporary therapy relies upon lifelong dietary protein restriction and supplementation with phenylalanine-free medical foods. This therapy is expensive and unpalatable; dietary compliance is difficult to maintain throughout life. Non-adherence to the diet...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.